Due to the increasing prevalence and highly infectious nature of Hepatitis A, CFA now offers an immunisation program for accredited confined space rescue personnel.
Whilst the initial vaccination involves a single injection, immunisation response can take up to two weeks to develop after vaccination. To prolong the protective effect, a single booster dose is recommended at any time between 6 and 12 months after the primary dose.
Immunisation is no excuse for carelessness or not ensuring high levels of hygiene.
The Hepatitis A vaccine is well tolerated. Most adverse events reported are mild and do not last more than 24 hours. Soreness at the injection site is the most frequently reported side effect but this should only last a short time. Less common side effects include skin rash, joint and muscle aches, headache, fever and nausea. Hepatitis A vaccines do not affect liver enzyme levels.
Pregnant and lactating women should delay being immunised against hepatitis A, unless there is a substantial risk of them coming into contact with the virus. Hepatitis A vaccine does not provide protection against other infectious diseases or other forms of hepatitis.
CFA regularly seeks medical advice as to the availability and suitability of new vaccines or the need to amend current immunisation practices. You can also consult your own doctor on these issues with particular regard to your own circumstances and health awareness.
For those personnel receiving immunisations, it is important that the following information is provided to their region to ensure the effectiveness of this program: